6 active trials 5 recruiting 4 disease areas
| Phase 1 | 4 | |
| Phase 1/2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT07501559 | A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in… | Recurrent Glioblastoma Multiforme(GBM) | Recruiting | 2026-08-10 |
| NCT07579741 | A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders | HIV Infections | Recruiting | 2026-08-06 |
| Phase 1 | ||||
| NCT07603479 | JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced… | Malignancies | Recruiting | 2026-08-11 |
| NCT07483970 | A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With… | High Risk Non-muscle Invasive Bladder Cancer | Recruiting | 2026-08-06 |
| NCT07623850 | A Phase I Study of JLM019 Injection | Advanced Solid Tumor (Phase 1) | Recruiting | 2026-06-03 |
| NCT07443228 | Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological… | HIV | Not Yet Recruiting | 2026-03-02 |
Non-Hodgkin Lymphoma (2) · Bladder Cancer (1) · Glioblastoma (1) · Hodgkin Lymphoma (1)